Nrf2 pathway is differentially regulated by AD in the PFC and Hippoc. The Nrf2 pathway is involved in the oxidative/nitrosative damage detected in the PFC, and AD has a therapeutic action through this pathway. It seems that Nrf2 is not involved in the effects caused by CMS in the Hippoc. The gene discussed is NFE2L2; the disease is Alzheimer disease.